Video

Marcelo Bigal, MD, PhD

Publish date: March 4, 2014

At the recent annual meeting of the Headache Cooperative of the Pacific, Marcelo Bigal, MD, PhD, discussed antibodies to treat migraine.

 

Online-Only Materials

AttachmentSize
File Bigal.mp4.mp455.21 MB

Recommended Reading

Analgesic Overuse May Worsen Chronic Post-Traumatic Headaches in Adolescents With Concussion
MDedge Neurology
Clinical Decision Rule Helps Identify Subarachnoid Hemorrhage
MDedge Neurology
Fine-Tuning the Ketogenic Diet May Benefit Children With Epilepsy—And Other News From the Child Neurology Society Meeting
MDedge Neurology
Perspectives on Migraine Trigger Site Deactivation Surgery
MDedge Neurology
Letter to the Editor—Migraine Headache Surgery: Time for More Studies
MDedge Neurology
Neuromodulation for Migraine—Promising, But Still Unproven
MDedge Neurology
RLS, Migraine, and Bruxism—Is There a Clinical Connection?
MDedge Neurology
Standard Combination Therapy Is Underused for Managing Migraine in Pediatric Emergency Department
MDedge Neurology
Neuromodulation for Cluster Headache—A Promising Area of Study
MDedge Neurology
Gretchen Tietjen, MD
MDedge Neurology